Kingston’s Laboratory Research
Our lab uses a variety of approaches to develop drugs from natural products. We collaborate with biologists and microbiologists to discover and develop potential drugs for treatment of cancer, malaria, leishmaniasis, and human African trypanosomiasis (sleeping sickness), and we also work to develop improved methods of drug delivery.
These approaches are illustrated by the projects below.
Exploring the Merck library of natural products extracts to find and study potential new antimalarial agents.
Using novel bioassay to discover inhibitors of the proteasome
Using gold nanoparticles to deliver anticancer drugs directly to the tumor site.
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience
The VaDDC Executive Committee is pleased to announce the VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience symposium will be held at the
Hotel Roanoke – May 21-22, 2019